Deal Announcement

Technology Holdings advises leading Strategic Healthcare Marketing Consultancy, Blue Latitude Health on its strategic sale to Fishawack

Technology Holdings is pleased to announce the strategic sale of our client, Blue Latitude Health to The Fishawack Group of Companies. Blue Latitude Health is a new breed of creative healthcare marketing consultancy, combining the commercial focus of a management consulting firm with the creative vision of an agency with offices in London and New York. Blue Latitude Health has extensive end-to-end experience in launching breakthrough portfolios, services and brands for the leading healthcare and life sciences companies such as Janssen, Pfizer, Bayer, Eli Lilly, Boehringer Ingelheim and Sanofi. Blue Latitude Health has the DNA of a digital marketing consultancy with expertise in design and execution of digital solutions, mapping future customer and patient needs, as well as developing and executing winning commercial strategies. As a creative consultancy made for modern healthcare, Blue Latitude Health is focused on the commercialization of healthcare innovations, globally and regionally at a brand, portfolio and organizational level with multichannel capabilities to serve client needs.

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in the UK, USA, Switzerland and India. Fishawack comprises two international divisions, Fishawack Medical Communications, developing and delivering services in the fields of medical communications, scientific engagement, publications, market access, strategic consultancy, and thought leader consultancy, and Fishawack Creative, offering strategic planning, creative development, advertising and promotion, and tactical execution.

“To enable us to continue to grow and provide existing and future clients with a stronger offering, we needed to find a partner who both shared our values and matched our ambition,” stated Martin Brass, Managing Director of Blue Latitude Health. “We believe we have found this partner in Fishawack. ” Fred Bassett, Head of Strategy and Co-founder of Blue Latitude Health, added, “We are thrilled to join an organization with the global scale and extended services in medical and scientific communications that Fishawack offers.”

“In 2016, we set out our vision to form a major new force in the global creative agency space that would make us as strong in the creative arena as we already are in medical communications,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “…We were actively looking for a consultancy that could bring strategic and customer experience expertise to our portfolio and Blue Latitude Health fits perfectly.”

“Many of our clients are wanting a partner that has specialist global capabilities both commercially and medically, and can ensure alignment of communication objectives,” commented Gail Flockhart, Group Managing Director of Fishawack. “Blue Latitude Health has a deep strategic consulting capability and brings us a base in New York City, from which we can continue to expand our East Coast creative and medical communications teams.”

From the get-go, TH got to know our business as if it were their own. They made it their business to understand not just the numbers but the story behind them. They expertly developed and helped us shortlist a field of potential buyers and negotiated the best possible deal. In doing this they left no stone unturned and have helped secure an exciting future for the business. TH gave us the confidence to control the process and our own destiny. Bravo.

Fred Bassett, Chairman & Founder - Blue Latitude Health

Martin Brass,
Founder & Managing Director - Blue Latitude Health

For more information please contact
Vivek Subramanyam
Founder & CEO
+44 7778 863 790 
Geeta Ramanathan
Managing Director
+44 7807 173 414


Disclaimer. All products and brand names mentioned are trademarks or registered trademarks of their respective owners. All Trademarks remain the property of their respective holders, and in no way indicates any relationship between Technology Holdings and the holders of said trademarks.